e-mails+regarding+request+of+pComb3XSS+vector+3-25-12

7 messages ||
 * Kurt Whittemore **
 * [[image:https://ssl.gstatic.com/images/icons/product/googlemail-32.png caption="Gmail Logo"]] || **RE: Material Transfer Agreement for pComb3XSS / Agr #2012-0170**

Cc: "Roberta P. Fuller" , Mishelle McClanahan-Shinn  ||
 * **Sharon Kwan**  || Fri, Mar 23, 2012 at 8:20 PM ||
 * To: Kurt Whittemore , "kathryn.sykes@asu.edu" 
 * || RE: Material Transfer Agreement for pComb3XSS / Agr #2012-0170

Dear Dr. Sykes and Dr. Whittemore:

Sincere apologies for the delay. I am trying hard to keep up with requests. Please don’t hesitate to bug me – the delay is my end.

Thank you for your interest in the phagemid pComb3XSS developed by Dr. Carlos Barbas, et. al. We are pleased to supply the vectors to you for use in your laboratory.

We view the free exchange of research materials as a right and duty of the academic community. However, to meet our obligations to the industrial sponsors of the research which resulted in the phagemid technology, we require a MTA before release of the vectors. Please also note that we require a $200 fee for preparation and shipment of materials.

Attached is the MTA (as .pdf and word for your convenience) for the pComb vectors. Upon describing your research project with the Materials in section 3, please return the MTA, signed by you and an authorized representative of your institution and payment of $200 at your earliest convenience. TSRI does not require hard copy originals - an emailed .pdf file to me is acceptable. If your institution requires hard copy originals, please mail the signed, duplicate hard copy originals to my attention at the address below. Upon fully executing the MTA and receipt of the payment, we will have the materials forwarded to you. Please contact me if I can be of further assistance.

Best regards, Sharon

 Sharon Kwan, Ph.D. <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">Office of Technology Development <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">The Scripps Research Institute <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">10550 North Torrey Pines Road, TPC-9 <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">La Jolla, CA 92037 <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">Phone: (858)784-8496 <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">Fax: (858)784-9910 <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">sharonk@scripps.edu

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">From: **<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> Kurt Whittemore [mailto:kurtwhittemore@gmail.com]

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> **Sent: **Thursday, March 22, 2012 8:00 AM

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> **To: **Sharon Kwan

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> **Cc: **Roberta P. Fuller

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> **Subject: **pcomb3xss material transfer agreement

Hi Sharon Kwan, I sent a material transfer agreement to obtain the pcomb3xss plasmid to Roberta Fuller on February 9th. I have attached the material transfer agreement again to this form. I am just curious about the status of this transfer. Is there any further action that I need to take? Will I be able to receive the plasmid fairly soon? Thanks for any help and information that you can offer! Best regards,

Kurt Whittemore Graduate Student

Arizona State University

BIODESIGN INSTITUTE

Center for Innovations in Medicine

1001 S McALLISTER AVE

TEMPE, AZ 85287 -- Forwarded message --

From:** Kurt Whittemore **<kurtwhittemore@gmail.com>

Date: Thu, Feb 9, 2012 at 5:50 PM

Subject: pcomb3xss material transfer agreement

To: rpfuller@scripps.edu

Hi Scripps Research Institute representative,

Here is my material transfer agreement request form for the pComb3XSS plasmid from the lab of Carlos Barbas. Thanks for your help!

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">Best regards,

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">Kurt Whittemore

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">Graduate Student

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">Arizona State University

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">BIODESIGN INSTITUTE

Center for Innovations in Medicine

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">1001 S McALLISTER AVE

<span style="font-family: 'Arial','sans-serif'; font-size: 14.6667px;">TEMPE, AZ 85287 ** |||| 2 attachments || 28K ||  ||   ||   ||
 * || [[image:https://mail.google.com/mail/u/0/images/pdf.gif width="16" height="16" link="@https://mail.google.com/mail/u/0/?ui=2&ik=e089a37ada&view=att&th=13642b809ef2d467&attid=0.1&disp=attd&safe=1&zw"]] ||  || 2012-0170.pdf
 * 225K** ||  ||
 * || [[image:https://mail.google.com/mail/u/0/images/doc.gif width="16" height="16" link="@https://mail.google.com/mail/u/0/?ui=2&ik=e089a37ada&view=att&th=13642b809ef2d467&attid=0.2&disp=attd&safe=1&zw"]] ||  || 2012-0170.docx**

Cc: Kurt Whittemore <Kurt.Whittemore@asu.edu> ||
 * **Kathryn Sykes** <Kathryn.Sykes@asu.edu> || Fri, Mar 23, 2012 at 10:08 PM ||
 * To: Pattie Madjidi <Pattie.Madjidi@asu.edu>
 * || <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">Pattie, we will want to move on this. I will fill out the MTA sections Monday


 * <span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">From: **<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> Sharon Kwan [mailto:sharonk@scripps.edu]

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**Sent:** Friday, March 23, 2012 8:20 PM

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**To:** Kurt Whittemore; Kathryn Sykes

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**Cc:** Roberta P. Fuller; Mishelle McClanahan-Shinn

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**Subject:** RE: Material Transfer Agreement for pComb3XSS / Agr #2012-0170 [Quoted text hidden] |||| **2 attachments** || 225K ||  || 28K ||  ||   ||   ||
 * || [[image:https://mail.google.com/mail/u/0/images/pdf.gif width="16" height="16" link="@https://mail.google.com/mail/u/0/?ui=2&ik=e089a37ada&view=att&th=136431b7e2a6190a&attid=0.1&disp=attd&safe=1&zw"]] ||  || **2012-0170.pdf**
 * || [[image:https://mail.google.com/mail/u/0/images/doc.gif width="16" height="16" link="@https://mail.google.com/mail/u/0/?ui=2&ik=e089a37ada&view=att&th=136431b7e2a6190a&attid=0.2&disp=attd&safe=1&zw"]] ||  || **2012-0170.docx**


 * **Kurt Whittemore** <kurtwhittemore@gmail.com> || Fri, Mar 23, 2012 at 10:13 PM ||
 * To: Kathryn Sykes <Kathryn.Sykes@asu.edu> ||
 * || Wow, strict document. Here's an example of what I mean: "When the Research Project is completed, or three (3) years have elapsed, whichever occurs first, the Research Material will be destroyed by RECIPIENT or otherwise disposed of as mutually agreed by provider and RECIPIENT."

Who will be the "authorized representative" (Pattie?) and who will be the "recipient" (you?) to sign this document?

-Kurt [Quoted text hidden] ||  ||


 * **Kathryn Sykes** <Kathryn.Sykes@asu.edu> || Sat, Mar 24, 2012 at 2:40 PM ||
 * To: Kurt Whittemore <Kurt.Whittemore@asu.edu> ||
 * || <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">Misty Matero is the authorized rep We can email it to her. I can be the recipient. Don’t worry about the language. You don’t need the original construct for more than 3 yrs. You will be modifying it into a library.


 * <span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">From: **<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> Kurt Whittemore [mailto:Kurt.Whittemore@asu.edu]

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**Sent:** Friday, March 23, 2012 10:14 PM

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**To:** Kathryn Sykes

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**Subject:** Re: FW: Material Transfer Agreement for pComb3XSS / Agr #2012-0170 [Quoted text hidden] ||  ||

[Quoted text hidden] ||  ||
 * **Kurt Whittemore** <kurtwhittemore@gmail.com> || Sun, Mar 25, 2012 at 7:19 AM ||
 * To: Kathryn Sykes <Kathryn.Sykes@asu.edu> ||
 * || Okay sounds good.


 * **Kathryn Sykes** <Kathryn.Sykes@asu.edu> || Sun, Mar 25, 2012 at 4:02 PM ||
 * To: Kurt Whittemore <Kurt.Whittemore@asu.edu> ||
 * || <span style="color: #1f497d; font-family: 'Calibri','sans-serif'; font-size: 14.6667px;">Go ahead and write a couple sentences about your use of the material then return it to me. Then I’ll get this passed along to the right channels.


 * <span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">From: **<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> Kurt Whittemore [mailto:Kurt.Whittemore@asu.edu]

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> **Sent:** Friday, March 23, 2012 10:14 PM

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;"> **To:** Kathryn Sykes

<span style="font-family: 'Tahoma','sans-serif'; font-size: 13.3333px;">**Subject:** Re: FW: Material Transfer Agreement for pComb3XSS / Agr #2012-0170 [Quoted text hidden] ||  ||


 * **Kurt Whittemore** <kurtwhittemore@gmail.com> || Sun, Mar 25, 2012 at 9:40 PM ||
 * To: Kathryn Sykes <Kathryn.Sykes@asu.edu> ||
 * || Maybe the following sentences could work. I tried to keep my descriptions somewhat broad in order to include a variety of uses for the vector.

The pComb3XSS vector research material will be used in the Antigen Discovery Project. This vector will aid in the construction of phage antibody libraries from the B cells of hosts. These phage antibody libraries can then be used to probe random peptide arrays as well as biological material for antigens unique to diseases.

-Kurt [Quoted text hidden] ||  ||